| Aug 1 |
Bionano Announces Presentation of Optical Genome Mapping Utility Across Cancer Research Applications at the Cancer Genomics Consortium (CGC) 2024 Annual Meeting
|
| Jul 31 |
Bionano Genomics files for up to 35M common stock offering by selling securityholders
|
| Jul 31 |
Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference
|
| Jul 31 |
Bionano to Report Second Quarter 2024 Financial Results and Host a Conference Call and Webcast on August 7, 2024
|
| Jul 23 |
Bionano Announces Publication of First Multi-Site Study to Analyze the Utility of OGM in Multiple Myeloma
|
| Jul 8 |
Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
|
| Jul 5 |
Bionano falls after $10M stock offering
|
| Jul 5 |
Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
|
| Jul 2 |
Bionano Announces Presentation of OGM Utility Across Stem Cell Therapy Applications at the International Society for Stem Cell Research (ISSCR) Annual Meeting
|
| Jun 20 |
Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research
|
